Inspire Medical Systems, Inc. - 8-K Filing

Inspire Medical Systems reports Q3 2026 revenue of $206.7 million and narrows full-year revenue guidance to $850M-$860M. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $INSP

Read the full article at SEC EDGAR

Part of the story Noble Corp plc - 8-K Filing (63 articles)

More Regulatory news